default author photo

Mark R. Wills

University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease

Cambridge CB2 0AW

United Kingdom

University of Cambridge - Department of Medicine

Cambridge CB2 0AW

United Kingdom

SCHOLARLY PAPERS

4

DOWNLOADS

536

TOTAL CITATIONS

1

Scholarly Papers (4)

1.

Age-Related Heterogeneity in Neutralising Antibody Responses to SARS-CoV-2 Following BNT162b2 Vaccination

Number of pages: 18 Posted: 11 Feb 2021
University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, University College London - Division of Infection and Immunity, NIHR Cambridge Clinic Research Facility - Addenbrooke's Hospital, NIHR Cambridge Biomedical Research Centre - NIHR BioResource, NIHR BioResource, NIHR Cambridge Biomedical Research Centre, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, NIHR Cambridge Clinic Research Facility - Addenbrooke's Hospital, Addenbrookes Hospital - Department of Clinical Biochemistry and Immunology, NIHR Cambridge Clinical Research Facility, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease and Cambridge Institute of Therapeutic Immunology & Infectious Disease
Downloads 254 (301,349)
Citation 1

Abstract:

Loading...

SARS-CoV-2; COVID-19; antibody; vaccine; neutralising antibodies

2.

B Cell Receptor Repertoire Kinetics after SARS-CoV-2 Infection and Vaccination

Number of pages: 51 Posted: 24 Aug 2021
University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Addenbrooke's Hospital - Division of Virology, University Hospital Basel - Immunobiology Laboratory, NHS Foundation Trust - Cambridge University Hospitals, University of Cambridge - Division of Virology, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge - Department of Medicine, University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease and University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease
Downloads 120 (596,393)

Abstract:

Loading...

3.

Retrospective Diagnosis of SARS-CoV-2 Infection in Patients with Long COVID by Measuring Specific T Cell Mediated IL-2 Release

Number of pages: 20 Posted: 27 Oct 2021
University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Cambridge University Teaching Hospital, Addenbrooke's - Department of Infectious Diseases, affiliation not provided to SSRN, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, National Institutes for Health Research (NIHR) Cambridge Biomedical Research Centre, University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Cambridge University NHS Hospitals Foundation Trust - Department of Infectious Diseases, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease and University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease
Downloads 103 (674,591)

Abstract:

Loading...

COVID, Long COVID, SARS-CoV-2, T cell assay, Interleukin-2, Interferon gamma, SARS-CoV2 antibodies/serology

4.

Early Immune Pathology and Persistent Dysregulation Characterise Severe COVID-19

Number of pages: 105 Posted: 29 Dec 2020
University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, University of Cambridge - MRC Biostatistics Unit, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, NIHR Cambridge Clinical Research Facility, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, NIHR Cambridge Clinic Research Facility - Addenbrooke's Hospital, University of Cambridge - Division of Virology, Cambridge Institute of Therapeutic Immunology & Infectious Disease, Addenbrooke's Hospital - Division of Virology, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, NIHR Cambridge Biomedical Research Centre - NIHR BioResource, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Murdoch University - The Centre for Computational and Systems Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - MRC Biostatistics Unit, NIHR Cambridge Clinic Research Facility - Addenbrooke's Hospital, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Hycult Biotech - R&D Department, University of Cambridge - Cambridge Institute for Medical Research, Independent, Royal Papworth HospitalUniversity of Cambridge - Heart and Lung Research Institute, University Hospital Basel - Immunobiology Laboratory, University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease and University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease
Downloads 59 (970,490)

Abstract:

Loading...